233 related articles for article (PubMed ID: 18324390)
1. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.
Glover EM; Davis M
Psychopharmacology (Berl); 2008 Jun; 198(2):167-80. PubMed ID: 18324390
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
3. Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states.
Fendt M; Mucha RF
Psychopharmacology (Berl); 2001 May; 155(3):242-50. PubMed ID: 11432686
[TBL] [Abstract][Full Text] [Related]
4. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
5. Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.
Harris AC; Gewirtz JC
Psychopharmacology (Berl); 2004 Jan; 171(2):140-7. PubMed ID: 13680079
[TBL] [Abstract][Full Text] [Related]
6. The acoustic startle response as a measure of behavioral dependence in rats.
Mansbach RS; Gold LH; Harris LS
Psychopharmacology (Berl); 1992; 108(1-2):40-6. PubMed ID: 1410145
[TBL] [Abstract][Full Text] [Related]
7. Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures.
Harris AC; Hanes SL; Gewirtz JC
Psychopharmacology (Berl); 2004 Nov; 176(3-4):266-73. PubMed ID: 15164157
[TBL] [Abstract][Full Text] [Related]
8. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
9. Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Rothwell PE; Thomas MJ; Gewirtz JC
Neuropsychopharmacology; 2009 Sep; 34(10):2285-95. PubMed ID: 19494807
[TBL] [Abstract][Full Text] [Related]
10. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
11. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
Liu J; Schulteis G
Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats.
Lin CR; Yang LC; You HL; Lee CT; Tai MH; Tan PH; Lin MW; Cheng JT
Anesth Analg; 2003 Jun; 96(6):1711-1716. PubMed ID: 12761002
[TBL] [Abstract][Full Text] [Related]
13. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
14. Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine.
Parker LA; Joshi A
Pharmacol Biochem Behav; 1998 Nov; 61(3):331-3. PubMed ID: 9768568
[TBL] [Abstract][Full Text] [Related]
15. Effects of narcotics and narcotic antagonists on operant behavior.
McMillan DE
Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
[No Abstract] [Full Text] [Related]
16. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
17. The acute administration of the selective dopamine D(3) receptor antagonist SB-277011A reverses conditioned place aversion produced by naloxone precipitated withdrawal from acute morphine administration in rats.
Rice OV; Gardner EL; Heidbreder CA; Ashby CR
Synapse; 2012 Jan; 66(1):85-7. PubMed ID: 21905128
[TBL] [Abstract][Full Text] [Related]
18. [Behavioural studies during the gestational-lactation period in morphine treated rats].
Sobor M; Timár J; Riba P; Király KP; Al-Khrasani M; Gyarmati Z; Fürst Z
Neuropsychopharmacol Hung; 2013 Dec; 15(4):239-51. PubMed ID: 24380965
[TBL] [Abstract][Full Text] [Related]
19. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
Ibuki T; Dunbar SA; Yaksh TL
Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
[TBL] [Abstract][Full Text] [Related]
20. Morphine and naloxone: effects on conditioned fear as measured with the potentiated startle paradigm.
Davis M
Eur J Pharmacol; 1979 Mar; 54(4):341-7. PubMed ID: 436933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
